4 This is the P-value for testing the null hypothesis of no overall interaction. 5 P 1st vs 2nd is the P-value for testing the null hypothesis that treatment effects in 1 st and 2 rd tertiles are the same. The same applies for P 1st vs 3rd and P 2nd vs 3rd For definitions, see legend to Table S2 . The interactions were significant between B vitamin treatment and DHA tertiles (P = 0.003) and EPA tertiles (P = 0.094). In the third tertile of the DHA concentration, the memory score in the B vitamin group was higher than in placebo (P = 0.002). In the B vitamin group, memory score in the 3 rd tertile of DHA was higher than in the 1 st tertile (P = 0.001). See Table S2 . In the B vitamin group, memory score in the 3 rd tertile of EPA was higher than in the 1 st tertile (P = 0.038). See Table S3 . Columns show mean scores and error bars SEM.
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Fig S2 TICS-M for placebo vs. B vitamin-treated at 2 year follow-up for A) DHA and B)
EPA tertiles. The interactions were significant between B vitamin treatment and DHA tertiles (P = 0.098), but not for EPA tertiles (P = 0.40). In the third tertile of the DHA concentration, the cognition score in the B vitamin group was higher than in placebo (P = 0.041). In the B vitamin group, memory score in the 3 rd tertile of DHA was higher than in the 1 st tertile (P = 0.039). See Tables S2 and S3 EPA tertiles. The interactions were significant between B vitamin treatment and DHA tertiles (P = 0.097), but not for EPA tertiles (P = 0.15). In the third tertile of the DHA concentration, the CDR score in the B vitamin group was lower than in placebo (P = 0.022).
In the B vitamin group, CDR score in the 3 rd tertile of DHA was lower than in the 1 st tertile (P = 0.034). See Tables S2 and S3 Table S4 . The likelihood ratio test for interaction between B vitamin treatment and DHA tertiles was significant (P = 0.025, Table  S6 ). In the 3 rd tertile of DHA, the average HVLT-DR significantly increased in the B vitamin group by 0.46 points per year of follow-up (P = 0.009) compared to no significant change in the placebo group (Table S6 ). The pattern for EPA was similar, but did not reach significance. Error bars indicate SEM.
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